Back to news

Ainos Reports Third Quarter 2026 Results and Highlights Expanding AI Nose Commercial Momentum

ACCESSWIRE•16/11/2026•08:30 ET
0

Key Highlights

  • ➤Q3 revenue $642,889, up 29,567% year over year
  • ➤GAAP net loss improved 36% year over year to $1.886 million
  • ➤$9 million AI Nose order covers 5,000 systems; $4.5 million due within 60 days
  • ➤1,400 AI Nose systems delivered under initial $2.1 million agreement
  • ➤Q4 recurring revenue expected at $175,000 quarterly under three-year service agreement

Expert Statements

Eddy Tsai, Chairman, President and Chief Executive Officer of Ainos

“Our third-quarter results show progress in translating commercial agreements into revenue. Revenue reached $642,889, up 29,567% year over year, driven by VELDONA licensing and our AI Nose semiconductor program. We delivered 1,400 AI Nose systems under our initial $2.1 million agreement and received initial orders from another semiconductor customer.”

Eddy Tsai, Chairman, President and Chief Executive Officer of Ainos

“Following quarter-end, our existing backend semiconductor customer signed a $9 million purchase agreement for 5,000 additional AI Nose systems-more than four times the value of the initial agreement. We believe this follow-on order is tangible evidence of customer demand for Chemical Intelligence in semiconductor manufacturing. As we execute the agreement and collect contractual payments, we expect it to support revenue growth and strengthen working capital.”

Eddy Tsai, Chairman, President and Chief Executive Officer of Ainos

“Our focus is on fulfilling customer commitments, expanding recurring services and directing operating resources toward Chemical Intelligence commercialization. Our chemical dataset grew from more than 1 billion records in September to over 3 billion in October, supporting product refinement and broader applications. Our potential $10 million VELDONA licensing framework provides a partner-funded path for assigned clinical and regulatory development while we retain core platform ownership.”

Christopher Lee, Chief Financial Officer of Ainos

“Our Q3 2026 results demonstrate progress in both revenue generation and operating discipline. GAAP net loss improved 36% year over year while non-GAAP adjusted net loss improved 51%. GAAP gross margin increased to 83.4% from 78.0% in the third quarter of 2025, while non-GAAP gross margin increased to 83.6% from 78.0%, excluding share-based compensation and depreciation and amortization allocated to cost of revenue. GAAP operating expense declined 20.3% year over year. These improvements benefited from the recognition of the one-time $600,000 initial VELDONA license fee and revenue from AI Nose semiconductor programs.”

Christopher Lee, Chief Financial Officer of Ainos

“Beginning in Q4 2026, we expect the $2.1 million AI Nose agreement to contribute approximately $175,000 in recurring revenue per quarter over the three-year service period, providing a more predictable revenue foundation.”

Christopher Lee, Chief Financial Officer of Ainos

“Following quarter-end, we collected $950,000 from the VELDONA license payment and AI Nose semiconductor commercialization. The $9 million follow-on AI Nose agreement provides for a $4.5 million initial payment within 60 days of signing. We have also begun discussions to address convertible-notes due in 2027. We believe these efforts will strengthen our working capital foundation and support the next phase of order execution.”

HOUSTON, TX / ACCESS Newswire / November 16, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced financial results for the third quarter ended September 30, 2026, highlighting increased revenue, a narrower net loss and progress in AI Nose semiconductor commercialization and VELDONA licensing. Subsequent to quarter-end, the Company secured an additional $9 million AI Nose order with $4.5 million initial payment due in 60 days, and collected $950,000 contractual payments.

Eddy Tsai, Chairman, President and Chief Executive Officer, commented:

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in